Joe Turgeon, President and Chief Executive Officer, to retire and step down from Board of Directors “We welcome Tom as the new CEO of Spectrum and look forward to the continued benefits of his ...

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call ...

BOSTON--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that ...

As 2012 nears its end, the rear-view mirror is full of ups and downs in the health care sector. One company that had plenty of both is small-cap Spectrum Pharmaceuticals. Here are the major milestones ...

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will ...

(RTTNews) - Spectrum Pharmaceuticals (SPPI) announced the appointment of Nora Brennan as Chief Financial Officer effective May 25, 2022. Brennan has served on the company's Board and as Chairperson of ...

U.S. FDA declines to approve Spectrum's lung cancer drug Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration (FDA) declined to approve its experimental lung cancer drug ...

Spectrum stockholders will receive contingent value rights, too, along with Assertio shares. The rewards are payable on achievement of 2024 and 2025 sales levels from Spectrum's lead drug. Rolvedon ...